(Q37686532)

22 August 2017

1 reference

title

RNA as performance-enhancers for dendritic cells (English)

1 reference

22 August 2017

1 reference

David Boczkowski

1

1 reference

22 August 2017

Smita Nair

series ordinal

2

1 reference

22 August 2017

language of work or name

English

0 references

publication date

1 April 2010

1 reference

Expert Opinion on Biological Therapy

22 August 2017

published in

1 reference

22 August 2017

volume

10

1 reference

22 August 2017

issue

4

1 reference

22 August 2017

page(s)

563-574

1 reference

Taking dendritic cells into medicine

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614749

21 January 2018

DC-based cancer vaccines

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614749

Dendritic cell immunotherapy: mapping the way.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614749

Dendritic cells in cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614749

Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614749

Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614749

Cancer immunotherapy: moving beyond current vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614749

Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614749

The therapeutic implications of intratumoral regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614749

Tregs and rethinking cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614749

Regulatory T cells, tumour immunity and immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614749

Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614749

Induction of cytotoxic T cell responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614749

Cancer immunotherapy with mRNA-transfected dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614749

RNA-transfected dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614749

Cancer immunotherapy using RNA-loaded dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614749

Dendritic cells engineered to secrete anti-GITR antibodies are effective adjuvants to dendritic cell-based immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614749

mRNA caps--old and newer hats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614749

Ectopic expression of a truncated CD40L protein from synthetic post-transcriptionally capped RNA in dendritic cells induces high levels of IL-12 secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614749

Untranslated regions of mRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614749

Structural and functional analysis of an mRNP complex that mediates the high stability of human beta-globin mRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614749

mRNA transfection of dendritic cells: synergistic effect of ARCA mRNA capping with Poly(A) chains in cis and in trans for a high protein expression level

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614749

Free poly(A) stimulates capped mRNA translation in vitro through the eIF4G-poly(A)-binding protein interaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614749

Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614749

Highly efficient gene delivery by mRNA electroporation in human hematopoietic cells: superiority to lipofection and passive pulsing of mRNA and to electroporation of plasmid cDNA for tumor antigen loading of dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614749

Side-by-side comparison of lentivirally transduced and mRNA-electroporated dendritic cells: implications for cancer immunotherapy protocols.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614749

Interleukin-12: biological properties and clinical application

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614749

High-level antigen expression and sustained antigen presentation in dendritic cells nucleofected with wild-type viral mRNA but not DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614749

Induction of Influenza Matrix Protein 1 and MelanA-specific T lymphocytes in vitro using mRNA-electroporated dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614749

Type 2 Bias of T cells expanded from the blood of melanoma patients switched to type 1 by IL-12p70 mRNA-transfected dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614749

Dendritic cells transfected with interleukin-12 and tumor-associated antigen messenger RNA induce high avidity cytotoxic T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614749

IL-1, IL-18, and IL-33 families of cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614749

Induction of human dendritic cell maturation using transfection with RNA encoding a dominant positive toll-like receptor 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614749

Single-step antigen loading and activation of dendritic cells by mRNA electroporation for the purpose of therapeutic vaccination in melanoma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614749

Timing and tuning of CD27-CD70 interactions: the impact of signal strength in setting the balance between adaptive responses and immunopathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614749

CD27 is required for generation and long-term maintenance of T cell immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614749

Enhancing the immunostimulatory function of dendritic cells by transfection with mRNA encoding OX40 ligand.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614749

Small interference RNA modulation of IL-10 in human monocyte-derived dendritic cells enhances the Th1 response

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614749

Vaccination with dendritic cells transfected with BAK and BAX siRNA enhances antigen-specific immune responses by prolonging dendritic cell life

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614749

Enhancing dendritic cell vaccine potency by combining a BAK/BAX siRNA-mediated antiapoptotic strategy to prolong dendritic cell life with an intracellular strategy to target antigen to lysosomal compartments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614749

Immunoproteasome down-modulation enhances the ability of dendritic cells to stimulate antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614749

siRNA and innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614749

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614749

Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614749

Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614749

Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614749

Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614749

Induction of inflammatory cytokines and interferon responses by double-stranded and single-stranded siRNAs is sequence-dependent and requires endosomal localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614749

Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614749

5'-Triphosphate RNA is the ligand for RIG-I

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614749

Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614749

The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614749

Gene therapy to target dendritic cells from blood to lymph nodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614749

Immune therapy for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614749

Immunostimulatory monoclonal antibodies for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614749

Cancer immunotherapy: co-stimulatory agonists and co-inhibitory antagonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614749

CD28 and CTLA-4 coreceptor expression and signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614749

Enhancement of antitumor immunity by CTLA-4 blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614749

CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614749

Combination immunotherapy of B16 melanoma using anti-cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and granulocyte/macrophage colony-stimulating factor (GM-CSF)-producing vaccines induces rejection of subcutaneous and metastatic tumors accomp

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614749

CTLA-4 blockade in combination with xenogeneic DNA vaccines enhances T-cell responses, tumor immunity and autoimmunity to self antigens in animal and cellular model systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614749

The role of the CTLA4 blockade in the treatment of malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614749

Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614749

Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614749

A pilot trial of CTLA-4 blockade with human anti-CTLA-4 in patients with hormone-refractory prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614749

Cytotoxic T-lymphocyte-associated antigen-4 blockage can induce autoimmune hypophysitis in patients with metastatic melanoma and renal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614749

Local secretion of anti-CTLA-4 enhances the therapeutic efficacy of a cancer immunotherapy with reduced evidence of systemic autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614749

GITR: a multifaceted regulator of immunity belonging to the tumor necrosis factor receptor superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614749

Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3+CD25+CD4+ regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614749

Glucocorticoid-induced TNF receptor family related gene activation overcomes tolerance/ignorance to melanoma differentiation antigens and enhances antitumor immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614749

Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614749

Agonist anti-GITR antibody enhances vaccine-induced CD8(+) T-cell responses and tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614749

In vivo ligation of glucocorticoid-induced TNF receptor enhances the T-cell immunity to herpes simplex virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614749

Regulatory T cell-resistant CD8+ T cells induced by glucocorticoid-induced tumor necrosis factor receptor signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614749

A new member of the tumor necrosis factor/nerve growth factor receptor family inhibits T cell receptor-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614749

Engagement of glucocorticoid-induced TNFR family-related receptor on effector T cells by its ligand mediates resistance to suppression by CD4+CD25+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614749

Costimulation via glucocorticoid-induced TNF receptor in both conventional and CD25+ regulatory CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614749

Development of humanized antibodies as cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614749

Induction of Polyclonal Prostate Cancer-Specific CTL Using Dendritic Cells Transfected with Amplified Tumor RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614749

Immunotherapy with Autologous, Human Dendritic Cells Transfected with Carcinoembryonic Antigen mRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614749

The Feasibility and Safety of Immunotherapy with Dendritic Cells Loaded with CEA mRNA Following Neoadjuvant Chemoradiotherapy and Resection of Pancreatic Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614749

Limited Amounts of Dendritic Cells Migrate into the T-Cell Area of Lymph Nodes but Have High Immune Activating Potential in Melanoma Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614749

10.1517/14712591003614749

21 January 2018

Identifiers

DOI

1 reference

22 August 2017

1 reference